Rare genetic variants in the CFI gene are associated with advanced age-related macular degeneration and commonly result in reduced serum factor I levels

Human Molecular Genetics
David KavanaghJohanna M Seddon

Abstract

To assess a potential diagnostic and therapeutic biomarker for age-related macular degeneration (AMD), we sequenced the complement factor I gene (CFI) in 2266 individuals with AMD and 1400 without, identifying 231 individuals with rare genetic variants. We evaluated the functional impact by measuring circulating serum factor I (FI) protein levels in individuals with and without rare CFI variants. The burden of very rare (frequency <1/1000) variants in CFI was strongly associated with disease (P = 1.1 × 10(-8)). In addition, we examined eight coding variants with counts ≥5 and saw evidence for association with AMD in three variants. Individuals with advanced AMD carrying a rare CFI variant had lower mean FI compared with non-AMD subjects carrying a variant (P < 0.001). Further new evidence that FI levels drive AMD risk comes from analyses showing individuals with a CFI rare variant and low FI were more likely to have advanced AMD (P = 5.6 × 10(-5)). Controlling for covariates, low FI increased the risk of advanced AMD among those with a variant compared with individuals without advanced AMD with a rare CFI variant (OR 13.6, P = 1.6 × 10(-4)), and also compared with control individuals without a rare CFI variant (OR 19.0, P = 1.1...Continue Reading

References

Jan 1, 1992·European Journal of Immunology·N JulenJ Ripoche
Aug 14, 2001·Archives of Ophthalmology·J M SeddonW Willett
Apr 14, 2004·Archives of Ophthalmology·David S FriedmanUNKNOWN Eye Diseases Prevalence Research Group
Jun 3, 2004·Journal of Medical Genetics·V Fremeaux-BacchiW H Fridman
Feb 7, 2006·Ophthalmology·Johanna M SeddonRon A Adelman
Apr 20, 2006·Blood·Jessica CaprioliUNKNOWN International Registry of Recurrent and Familial HUS/TTP
May 23, 2007·The Journal of Experimental Medicine·Matthew C PickeringMarina Botto
Jun 19, 2008·American Journal of Transplantation : Official Journal of the American Society of Transplantation and the American Society of Transplant Surgeons·M Le QuintrecV Frémeaux-Bacchi
Aug 8, 2008·European Journal of Human Genetics : EJHG·Jesen A FagernessJohanna M Seddon
May 21, 2009·The Journal of Immunology : Official Journal of the American Association of Immunologists·Viviana P FerreiraDavid Kavanagh
Jul 16, 2009·European Journal of Human Genetics : EJHG·Sarah EnnisAndrew J Lotery
Aug 8, 2009·Investigative Ophthalmology & Visual Science·Robyn ReynoldsJohanna M Seddon
Jan 12, 2010·Annals of Human Genetics·Maren SullivanHartmut P H Neumann
Jan 29, 2010·Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association·Dineke WestraLambert van den Heuvel
Apr 1, 2010·Nature Methods·Ivan A AdzhubeiShamil R Sunyaev
Jan 1, 2009·Advances in Immunology·Peter J Lachmann
Jul 3, 2010·Clinical Journal of the American Society of Nephrology : CJASN·Marina NorisGiuseppe Remuzzi
May 3, 2011·Molecular Immunology·Sara C NilssonAnna M Blom
Oct 25, 2011·Nature Genetics·Soumya RaychaudhuriJohanna M Seddon
May 9, 2012·Lancet·Laurence S LimTien Y Wong
Jul 4, 2012·Trends in Immunology·Claire L HarrisB Paul Morgan
Aug 21, 2012·Pediatric Nephrology : Journal of the International Pediatric Nephrology Association·F Semsa CayciGokce Gur
Jan 12, 2013·Clinical Journal of the American Society of Nephrology : CJASN·Véronique Fremeaux-BacchiChantal Loirat
Feb 23, 2013·Journal of the American Society of Nephrology : JASN·Elena BresinUNKNOWN European Working Party on Complement Genetics in Renal Diseases
Mar 5, 2013·Nature Genetics·Lars G FritscheUNKNOWN AMD Gene Consortium
May 21, 2013·Nature Genetics·Johannes P H van de VenAnneke I den Hollander
May 25, 2013·Nature Reviews. Immunology·Jayakrishna AmbatiBradley D Gelfand
Jul 3, 2013·Molecular Immunology·Edwin K S WongDavid Kavanagh
Oct 29, 2013·Seminars in Nephrology·David KavanaghAnna Richards
Jan 1, 2014·Progress in Retinal and Eye Research·Lucia Sobrin, Johanna M Seddon

❮ Previous
Next ❯

Citations

Jan 9, 2016·Immunobiology·Menno van Lookeren CampagneBrian L Yaspan
May 15, 2016·Transfusion and Apheresis Science : Official Journal of the World Apheresis Association : Official Journal of the European Society for Haemapheresis·Paula Vieira-MartinsVeronique Fremeaux-Bacchi
May 18, 2016·Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association·Thurid Ahlenstiel-GrunowLars Pape
Nov 2, 2016·Clinical Journal of the American Society of Nephrology : CJASN·Fadi FakhouriVéronique Frémeaux-Bacchi
Oct 8, 2017·Seminars in Immunopathology·Claire L Harris
Jun 10, 2017·Clinical Journal of the American Society of Nephrology : CJASN·Alexandra BruelFadi Fakhouri
Jun 24, 2017·Science Translational Medicine·Brian L YaspanUNKNOWN MAHALO Study Investigators
Mar 21, 2020·Asia-Pacific Journal of Ophthalmology·Li Jia Chen
Jul 9, 2020·Clinical and Experimental Immunology·S UgrinovicE Gkrania-Klotsas
Jun 23, 2016·Human Genomics·Perciliz L TanNicholas Katsanis
Mar 14, 2018·The Journal of Immunology : Official Journal of the American Association of Immunologists·Xiaobo WuCharles A Harris
Sep 28, 2017·Seminars in Immunopathology·Simon J Clark, Paul N Bishop
Aug 24, 2019·Frontiers in Immunology·Carine El SissyVéronique Frémeaux-Bacchi
Apr 25, 2021·BioDrugs : Clinical Immunotherapeutics, Biopharmaceuticals and Gene Therapy·Hannah J Yu, Charles C Wykoff

❮ Previous
Next ❯

Methods Mentioned

BETA
blood draw
PCR
electrophoresis

Software Mentioned

PolyPhen2
PLINK
SAS
CONSED

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.